Market Blog Trending

Some Investors bought $KITE at $87.8

It's always incredible for a company developing a new innovation in an existing field when its tech yields satisfying results. Recent news of the Kite Pharma (NASDAQ: KITE) acquisition by Gilead Sciences (NASDAQ: GILD) for close to $12 billion and the general rise of the KITE stock even prior to the acquisition - from $87.8 in mid-June all the way to over $179 yesterday - has been thrilling to watch. To say the